Toxoplasmosis, CerebralEncephalitisPyrimethamineTrimethoprimSulfadiazineToxoplasmaToxoplasmosis, AnimalAtovaquoneToxoplasmosisAIDS-Related Opportunistic InfectionsTrimethoprim ResistanceAntiprotozoal AgentsNaphthoquinonesEncephalitis, ViralEncephalitis, JapaneseEncephalitis Virus, JapaneseClindamycinSulfamethoxazoleSulfadoxineTetrahydrofolate DehydrogenaseFolic Acid AntagonistsDapsoneAntimalarialsSulfanilamidesDrug CombinationsAcquired Immunodeficiency SyndromeTrimethoprim-Sulfamethoxazole CombinationLimbic EncephalitisEncephalitis, ArbovirusEncephalitis Virus, Venezuelan EquineDrug ResistanceEncephalitis, Herpes SimplexProguanilBrainEncephalitis, St. LouisEncephalitis VirusesEncephalitis Virus, St. LouisPlasmodium falciparumChloroquineDihydropteroate SynthaseJapanese Encephalitis VaccinesInterferon-gammaEncephalitis Virus, Eastern EquineMalaria, FalciparumAnti-Infective Agents, UrinaryTreatment OutcomeEncephalitis Virus, Western EquineDrug Therapy, CombinationAnti-Bacterial AgentsParasitic Sensitivity TestsEncephalomyelitis, Venezuelan EquineSulfaleneAnti-N-Methyl-D-Aspartate Receptor EncephalitisDrug Resistance, MicrobialAnti-Infective AgentsEncephalitis Virus, Murray ValleyEncephalomyelitis, EquineMicrobial Sensitivity TestsEncephalitis, CaliforniaMalariaDNA, ProtozoanTriazinesGangliosidoses, GM2R FactorsPneumonia, PneumocystisEncephalitis Viruses, JapaneseMefloquineFlavivirusArtemisininsUrinary Tract InfectionsCongoSesquiterpenesTime FactorsSulfamerazineChorioretinitisTrimetrexateCameroonCoccidiostatsCombined Modality TherapyFlavivirus Infections